Navigation Links
Prostate Cancer Therapeutics Market Worth $8.0 billion by 2019
Date:11/19/2013

ble 1: Prostate Cancer Therapeutics, Prostate Cancer Risk Factors
Table 2: Prostate Cancer Therapeutics, Prostate Cancer Staging
Table 3: Prostate Cancer Therapeutics, Abbreviations
Table 4: Prostate Cancer Therapeutics, Sources for Heat Map
Table 5: Prostate Cancer Therapeutics, Global, All Pipeline Products (Discovery), 2013
Table 6: Prostate Cancer Therapeutics, Global, All Pipeline Products (Preclinical/IND Filed), 2013
Table 7: Prostate Cancer Therapeutics, Global, All Pipeline Products (Phase I), 2013
Table 8: Prostate Cancer Therapeutics, Global, All Pipeline Products (Phase II), 2013
Table 9: Prostate Cancer Therapeutics, Global, All Pipeline Products (Phase III/Pre-Registration), 2013
Table 10: Prostate Cancer Therapeutics, Global, All Pipeline Products (Undisclosed Stage of Development), 2013
Table 11: Prostate Cancer, Leading Eight Markets, Market Forecast, 2012–2019
Table 12: Prostate Cancer, US, Market Forecast, 2012–2019
Table 13: Prostate Cancer, UK, Market Forecast, 2012–2019
Table 14: Prostate Cancer, France, Market Forecast, 2012–2019
Table 15: Prostate Cancer, Germany, Market Forecast, 2012–2019
Table 16: Prostate Cancer, Italy, Market Forecast, 2012–2019
Table 17: Prostate Cancer, Spain, Market Forecast, 2012–2019
Table 18: Prostate Cancer, Japan, Market Forecast, 2012–2019
Table 19: Prostate Cancer, Canada, Market Forecast, 2012–2019

Comprehensive Table of Contents and more for the report "Prostate Cancer Therapeutics Market to 2019 – Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019" is available at

SOURCE RnR Market Research
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
2. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
3. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
4. US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
5. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
6. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
7. Arkansas Prostate Cancer Center Earns High Honor of ACR-ASTRO Accreditation
8. Breakthrough Prostate Cancer Diagnostics
9. New Research Reveals Some Natural Supplements Effective Against Prostate Cancer
10. Prostate Cancer and Bone Health
11. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... SEATTLE , BERKELEY, Kalifornien, und KOPENHAGEN, ... CMC Biologics, Inc. , ein Weltmarktführer der ... und anderen therapeutischen Proteinen, gab heute bekannt, ... Expansionsstrategie der Produktionskapazität den Ausbau der nordamerikanischen ... , mit der Ergänzung  einer Einweg-Anlage Bioreactor ...
(Date:6/30/2015)... 2015  Marken, the leading clinical trial logistics organization ... has been granted permission by the government to deliver ... product in Korea.  This precedent-setting shipment has allowed several ... continue receiving their clinical trial drugs during the outbreak ... emergency was caused by recent partial closures of medical ...
(Date:6/30/2015)... PharmaVentures is pleased to announce ... Oy (CMT) on its divestment of certain assets to ... world leading capabilities in cellular imaging and analysis. ... of successful global deals in the life science research ... Walton , CEO, PharmaVentures, commented: "PharmaVentures is delighted to ...
Breaking Medicine Technology:CMC Biologics baut GMP-Produktionskapazität in den USA aus 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 3Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2
... WORTH, Texas, Aug. 26 Healthpoint today announced,that ... the effectiveness of a,widely prescribed enzymatic debriding agent ... study was prompted, in part, by clinical reports,of ... healing,properties associated with Collagenase SANTYL(R) Ointment.(1,2), "Given ...
... Inc.,(Nasdaq: XTNT ) today announced that the positive ... in the most recent issue of the,peer-reviewed journal, EuroIntervention. ... Stella, M.D., of University Medical Center Utrecht, Utrecht,The Netherlands ... clinical,sites across Europe., The one-year CUSTOM II trial, ...
Cached Medicine Technology:Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4
(Date:6/30/2015)... Chicago, IL (PRWEB) , ... June 30, 2015 , ... ... to educate women on fertility preservation and deciding the right age to pursue egg ... child until after the age of 35 — a 150 percent increase since the ...
(Date:6/30/2015)... ... June 30, 2015 , ... The American Lung Association in ... media event in San Diego. Speakers and clean air advocates included San Diego County ... Germuska of Kindred Hospital, and Daniel Sullivan, founder and president of Sullivan Solar Power. ...
(Date:6/30/2015)... ... June 30, 2015 , ... ADVOCATE, the premier ... been awarded the exclusive billing agreements with Jackson Radiology Associates in Jackson, TN. ... their proprietary suite of billing process software functionality called Experience Based Technology (EBTTM). ...
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... Broadway ... Nursing”, which features multiple patient and family member testimonials. Medicare rated the care center ... Broadway plans to use the video to give future patients a firsthand look at ...
(Date:6/30/2015)... ... June 30, 2015 , ... Family and professional dementia ... Symposium on November 9, 2015 at the Hyatt Regency Denver Tech Center from ... Kim and Ashley Campbell, the wife and daughter of singer Glen Campbell, who ...
Breaking Medicine News(10 mins):Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2
... who are in the process of developing a blood test ... than a mammogram, need the help of thousands of people ... spin-out company Oncimmune pioneers anti-cancer technology, and has reached the ... response to breast cancer. , The initial ...
... can keep disease from recurring , , MONDAY, April 21 (HealthDay ... recurrence of the disease and live longer, yet cancer survivors ... of the general population, according to new research. , ... Cancer , found that less than one-quarter of cancer survivors ...
... That Celebrates Daily Victories Over ... Parkinson,s, ... A number of people with Parkinson,s disease (PD), an age-related,degenerative disorder of ... penned their own inspirational story compiled in a new,book titled "Proud Hands." ...
... Performed at Significantly Reduced Cost at ... Genesis Medical Center -, - New Study Shows Greater than $1,650 Savings Per ... ... CRDC ) and Genesis Medical Center today reported results from a,six-month economic analysis comparing ...
... Outlook Reaffirmed -, MADISON, N.J., April 21 ... provider of diagnostic,testing, information and services, announced that for ... operations was $141 million,or $0.72 per diluted share, compared ... first quarter of 2007. Included in the results for ...
... Echo Therapeutics,(OTC Bulletin Board: ECTE) today ... and transdermal drug delivery technology right of ... capital affiliate of Cato,Research, a global contract ... exclusive rights of first negotiation to all,dermatology ...
Cached Medicine News:Health News:Thousands of volunteers needed to help bring cure for cancer closer 2Health News:Many Cancer Survivors Are Overweight and Sedentary: Study 2Health News:Many Cancer Survivors Are Overweight and Sedentary: Study 3Health News:'Proud Hands' Book Released to Benefit the American Parkinson Disease Association 2Health News:'Proud Hands' Book Released to Benefit the American Parkinson Disease Association 3Health News:'Proud Hands' Book Released to Benefit the American Parkinson Disease Association 4Health News:'Proud Hands' Book Released to Benefit the American Parkinson Disease Association 5Health News:Cardica's C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study 2Health News:Cardica's C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study 3Health News:Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008 2Health News:Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008 3Health News:Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008 4Health News:Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008 5Health News:Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008 6Health News:Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008 7Health News:Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008 8Health News:Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008 9Health News:Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008 10Health News:Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008 11Health News:Echo Therapeutics and Cato BioVentures Sign Right of First Offer Agreement for Dermatology Products and Transdermal Drug Delivery Technologies 2Health News:Echo Therapeutics and Cato BioVentures Sign Right of First Offer Agreement for Dermatology Products and Transdermal Drug Delivery Technologies 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: